Kyverna Therapeutics, Inc. Common Stock
KYTX
$6.39+3.40%
End of day · as of Oct 12, 2026, 9:01 AM ET
Mkt cap
$488.79M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-1.29
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Use this KYTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KYTX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company in the Healthcare sector.
Latest cached Kyverna Therapeutics, Inc. Common Stock (KYTX) net income for FY2025 was -$161.3M. Statements: https://lician.com/financials/kytx
Kyverna Therapeutics, Inc. Common Stock (KYTX) market capitalization is $488.8M on the latest cached snapshot.
Kyverna Therapeutics, Inc. Common Stock (KYTX) cached previous close $6.18; day range $6.18 – $6.58; volume 876,390. Session quote: https://lician.com/quote/kytx
Kyverna Therapeutics, Inc. Common Stock (KYTX) latest cached earnings event is "KYTX earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KYTX filing is 8-K · Sep 24, 2026. Filings: https://lician.com/sec/kytx